Printer Friendly

Strategy developed to improve delivery of medicines to the brain.

New research offers a possible strategy for treating central nervous system diseases, such as brain and spinal cord injury, brain cancer, epilepsy, and neurological complications of HIV. The experimental treatment method allows small therapeutic agents to safely cross the blood-brain barrier in laboratory rats by turning off P-glycoprotein, one of the main gatekeepers preventing medicinal drugs from reaching their intended targets in the brain.

To read the full text of this article, click here: http://www.nih.gov/news/health/sep2012/niehs-07.htm

COPYRIGHT 2012 National Institutes of Health
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:National Institutes of Health: News and Events
Article Type:Brief article
Geographic Code:1USA
Date:Sep 7, 2012
Words:129
Previous Article:TCGA discovers potential therapeutic targets for lung squamous cell carcinoma.
Next Article:NIBIB and HHMI announce graduate biomedical training awards.
Topics:

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |